MiMedx Group Inc (MDXG) Stock Analysis

MiMedx Group Inc (MDXG) is a publicly traded company in the HEALTHCARE sector. It trades at $3.58, carries a market capitalization of $533.23M, a price-to-earnings ratio of 17.90. This page summarizes the public market data, fundamentals, and frequently asked questions for MDXG, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

MiMedx Group Inc currently has a Neutral sentiment score of 0.06.

About MiMedx Group Inc

MiMedx Group, Inc. (MDXG) is a leading regenerative medicine company headquartered in Marietta, Georgia, specializing in the development and distribution of cutting-edge placental tissue allografts. These innovative products play a vital role in both wound care and surgical applications, significantly enhancing healing processes and improving patient outcomes. Leveraging proprietary technologies and a strong research foundation, MiMedx is strategically positioned to meet the dynamic needs of ...

GNG Research Analysis

GNG Research scores MiMedx Group Inc (MDXG) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for MDXG.

Frequently Asked Questions

Does MDXG pay dividends?

MiMedx Group Inc (MDXG) does not currently pay a regular dividend.

What is MDXG's P/E ratio?

MiMedx Group Inc has a price-to-earnings (P/E) ratio of 17.90.

What is MDXG's market cap?

MiMedx Group Inc (MDXG) has a market capitalization of $533.23M with a current stock price of $3.58.